Evidence

Brave AI and NICE Evidence Standards Framework

NICE ECD7Tier C DHTUKCA Class I Medical DeviceAll 21 standards addressed

Classification

Tier C Digital Health Technology

Brave AI is a Tier C DHT under the NICE Evidence Standards Framework. Tier C applies to technologies that inform clinical management and where incorrect use could directly result in patient harm. As a UKCA Class I regulated medical device, Brave AI is subject to the most stringent NICE evidence requirements.

21/21
Standards met
Tier C
NICE tier
UKCA I
Device class
ECD7 2022
Framework version
Met
Partial
Ongoing

Design Factors

Describing Value

Demonstrating Performance

Delivering Value

Deployment Considerations

Notes

This mapping reflects Bering Limited's own assessment of Brave AI against the NICE Evidence Standards Framework for Digital Health Technologies (ECD7). It has not been independently verified by NICE. The NICE ESF is available at nice.org.uk/corporate/ecd7.

Supporting documentation, including the Clinical Safety Case Report, Derivation and Validation Report, Health Economic Report, and Instructions for Use, is available to NHS procurement teams on request.